Cargando…

Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program

BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahonkhai, Aima A., Noubary, Farzad, Munro, Alison, Stark, Ruth, Wilke, Marisa, Freedberg, Kenneth A., Wood, Robin, Losina, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299719/
https://www.ncbi.nlm.nih.gov/pubmed/22427925
http://dx.doi.org/10.1371/journal.pone.0032993
_version_ 1782226156757450752
author Ahonkhai, Aima A.
Noubary, Farzad
Munro, Alison
Stark, Ruth
Wilke, Marisa
Freedberg, Kenneth A.
Wood, Robin
Losina, Elena
author_facet Ahonkhai, Aima A.
Noubary, Farzad
Munro, Alison
Stark, Ruth
Wilke, Marisa
Freedberg, Kenneth A.
Wood, Robin
Losina, Elena
author_sort Ahonkhai, Aima A.
collection PubMed
description BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective cohort study of 11,397 adults initiating antiretroviral therapy (ART) in 71 Southern African Catholic Bishops Conference/Catholic Relief Services HIV treatment clinics between January 2004 and December 2008. We distinguished among patients with early death, within the first 7 months on ART; patients with interruptions in laboratory monitoring (ILM), defined as missing visits in the first 7 months on ART, but returning to care by 12 months; and those LTFU, defined as missing all follow-up visits in the first 12 months on ART. We used multilevel logistic regression models to determine patient and clinic-level characteristics associated with these outcomes. RESULTS: In the first year on ART, 60% of patients remained in care, 30% missed laboratory visits, and 10% suffered early death. Of the 3,194 patients who missed laboratory visits, 40% had ILM, resuming care by 12 months. After 12 months on ART, patients with ILM had a 30% increase in detectable viremia compared to those who remained in care. Risk of LTFU decreased with increasing enrollment year, and was lowest for patients who enrolled in 2008 compared to 2004 [OR 0.49, 95%CI 0.39–0.62]. CONCLUSIONS: In a large community-based cohort in South Africa, nearly 30% of patients miss follow-up visits for CD4 monitoring in the first year after starting ART. Of those, 40% have ILM but return to clinic with worse virologic outcomes than those who remain in care. The risk of chronic LTFU decreased with enrollment year. As ART availability increases, interruptions in care may become more common, and should be accounted for in addressing program LTFU.
format Online
Article
Text
id pubmed-3299719
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32997192012-03-16 Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program Ahonkhai, Aima A. Noubary, Farzad Munro, Alison Stark, Ruth Wilke, Marisa Freedberg, Kenneth A. Wood, Robin Losina, Elena PLoS One Research Article BACKGROUND: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. METHODS: We conducted a retrospective cohort study of 11,397 adults initiating antiretroviral therapy (ART) in 71 Southern African Catholic Bishops Conference/Catholic Relief Services HIV treatment clinics between January 2004 and December 2008. We distinguished among patients with early death, within the first 7 months on ART; patients with interruptions in laboratory monitoring (ILM), defined as missing visits in the first 7 months on ART, but returning to care by 12 months; and those LTFU, defined as missing all follow-up visits in the first 12 months on ART. We used multilevel logistic regression models to determine patient and clinic-level characteristics associated with these outcomes. RESULTS: In the first year on ART, 60% of patients remained in care, 30% missed laboratory visits, and 10% suffered early death. Of the 3,194 patients who missed laboratory visits, 40% had ILM, resuming care by 12 months. After 12 months on ART, patients with ILM had a 30% increase in detectable viremia compared to those who remained in care. Risk of LTFU decreased with increasing enrollment year, and was lowest for patients who enrolled in 2008 compared to 2004 [OR 0.49, 95%CI 0.39–0.62]. CONCLUSIONS: In a large community-based cohort in South Africa, nearly 30% of patients miss follow-up visits for CD4 monitoring in the first year after starting ART. Of those, 40% have ILM but return to clinic with worse virologic outcomes than those who remain in care. The risk of chronic LTFU decreased with enrollment year. As ART availability increases, interruptions in care may become more common, and should be accounted for in addressing program LTFU. Public Library of Science 2012-03-12 /pmc/articles/PMC3299719/ /pubmed/22427925 http://dx.doi.org/10.1371/journal.pone.0032993 Text en Ahonkhai et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ahonkhai, Aima A.
Noubary, Farzad
Munro, Alison
Stark, Ruth
Wilke, Marisa
Freedberg, Kenneth A.
Wood, Robin
Losina, Elena
Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title_full Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title_fullStr Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title_full_unstemmed Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title_short Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program
title_sort not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (ltfu) in a large south african treatment program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299719/
https://www.ncbi.nlm.nih.gov/pubmed/22427925
http://dx.doi.org/10.1371/journal.pone.0032993
work_keys_str_mv AT ahonkhaiaimaa notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT noubaryfarzad notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT munroalison notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT starkruth notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT wilkemarisa notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT freedbergkennetha notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT woodrobin notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram
AT losinaelena notallarelostinterruptedlaboratorymonitoringearlydeathandlosstofollowupltfuinalargesouthafricantreatmentprogram